Navigation Links
Watson Confirms Vyvanse® Patent Challenge
Date:7/7/2011

d-looking statements that reflect Watson's current perspective of existing information as of the date of this release. It is important to note that Watson's goals and expectations are not predictions of actual performance. Actual results may differ materially from Watson's current expectations depending upon a number of factors, risks and uncertainties affecting Watson's business. These factors include, among others, the difficulty of predicting the timing or outcome of product development efforts, including FDA and other regulatory agency approvals and actions, if any; the difficulty of predicting the timing and outcome of the pending patent litigation; the impact of competitive products and pricing; the timing and success of product launches; difficulties or delays in manufacturing; the availability and pricing of third party sourced products and materials; successful compliance with FDA and other governmental regulations applicable to Watson and its third party manufacturers' facilities, products and/or businesses; changes in the laws and regulations, including Medicare and Medicaid, affecting among other things, pricing and reimbursement of pharmaceutical products; and such other risks and uncertainties detailed in Watson's periodic public filings with the Securities and Exchange Commission, including but not limited to Watson's quarterly report on form 10-Q for the quarter ended March 31, 2011 and Watson's annual report on Form 10-K for the year ended December 31, 2010. Except as expressly required by law, Watson disclaims any intent or obligation to update these forward-looking statements.

Vyvanse®  is a registered trademark of Shire LLC.

(Logo: http://photos.prnewswire.com/prnh/20100121/LA41294LOGO)CONTACTS:Investors:Patty Eisenhaur(862) 261-8141Media:Charlie Mayr(862) 261-8030
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Watson Launches Generic Biaxin(R) XL
2. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
3. Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia
4. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
5. Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
6. Watson and Barr Settle Lawsuit Over Oxytrol(R)
7. Watson to Host Conference Call and Webcast to Discuss Fourth Quarter 2009 Earnings and 2010 Outlook
8. Watson Completes Acquisition of Eden Biodesign
9. Watson to Present at Credit Suisse Healthcare Conference
10. Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy
11. Watson Files FDA Application for Generic Rozerem(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... PRUSSIA, Pa. , March 30, 2015 /PRNewswire/ ... European Medicines Agency (EMA) has started the Centralized ... (MAA) for its long-acting fusion protein linking recombinant ... European Commission approval, rIX-FP will provide hemophilia B ... as the European Economic Area (EEA) countries, with ...
(Date:3/30/2015)... , March 30, 2015 Sorrento Therapeutics, ... of George K. Ng to the position ... this capacity, Mr. Ng will be responsible for all ... Ng joins the Company from BioDelivery Sciences International, Inc., ... and a member of senior management that led that ...
(Date:3/30/2015)... March 30, 2015  BioPharmX Corporation (OTCQB: BPMX), ... of novel drug delivery products to address unmet ... announced the appointment of Stephen Morlock , ... to its board of directors.  Mr. Morlock,s background ... expand its national roll-out of Violet iodine, the ...
Breaking Medicine Technology:European Medicines Agency Commences Review of CSL Behring's Regulatory Submission for rIX-FP for Hemophilia B Patients 2European Medicines Agency Commences Review of CSL Behring's Regulatory Submission for rIX-FP for Hemophilia B Patients 3European Medicines Agency Commences Review of CSL Behring's Regulatory Submission for rIX-FP for Hemophilia B Patients 4Sorrento Announces Appointment Of George Ng As EVP & Chief Legal Officer 2Sorrento Announces Appointment Of George Ng As EVP & Chief Legal Officer 3BioPharmX Corporation Appoints Stephen Morlock To Its Board Of Directors 2BioPharmX Corporation Appoints Stephen Morlock To Its Board Of Directors 3
... announces that a new market research report is available ... Markets and Companies http://www.reportlinker.com/p0203546/Neuroprotection---Drugs-Markets-and-Companies.html ... neuroprotection in acute disorders such as stroke and injuries ... diseases such as neurodegenerative disorders because many of the ...
... Amarin Corporation plc (Nasdaq: AMRN ) has scheduled ... am Eastern Time (4:00 pm UTC/GMT) to discuss selected financial ... update of the Company,s MARINE and ANCHOR trials, the two ... AMR101 for treating elevated triglyceride levels in separate patient populations. ...
Cached Medicine Technology:Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 2Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 3Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 4Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 5Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 6Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 7Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 8Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 9Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 10Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 11Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 12Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 13Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 14Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 15Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 16Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 17Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 18Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 19Reportlinker Adds Neuroprotection - Drugs, Markets and Companies 20Amarin Corporation to Host Investor Conference Call on Wednesday, November 10, 2010 2
(Date:3/30/2015)... March 31, 2015 Healtheminds, a start-up ... services through an innovative, easy to use and engaging ... create awareness about mental health related issues. The first ... to alcohol, tobacco and other drugs. , Consumption ... health effects. These include the toxic effects of excessive ...
(Date:3/30/2015)... Wright & Schulte LLC, who is currently ... number of Syngenta corn lawsuits now pending ... Court, District of Kansas, have risen sharply since the ... update released by the U.S. Judicial Panel on Multidistrict ... lawsuits are now consolidated in the federal litigation, all ...
(Date:3/30/2015)... Southern Med Law, a law firm ... has filed a Mirena IUD lawsuit on ... his premature birth in 2012. The complaint, which is ... the Mirena IUD failed to prevent pregnancy due to ... difficult to remove. The inability to remove the IUD ...
(Date:3/30/2015)... 30, 2015 “We are pleased to ... Awards on May 30 in Los Angeles,” said Mark ... volunteers pilots nominated from a nationwide call for nominations. ... Angel Flight Mid-Atlantic, Richard Durden with LightHawk and Stephen ... by the award recipients will receive a $15,000 contribution ...
(Date:3/30/2015)... Innovaacom, a leading provider of medical ... it is expanding its services into Asia in 2015. ... the world comes at a time when Asia’s strengthening ... better healthcare. A rapidly growing aging population and changing ... in medicine in Asia. “We are excited to be ...
Breaking Medicine News(10 mins):Health News:HealthEminds Launching Webinar on Drug Dependence 2Health News:Syngenta Corn Lawsuit Claims Continue To Be Filed By Non GMO Corn Farmers Reports Wright & Schulte LLC 2Health News:Syngenta Corn Lawsuit Claims Continue To Be Filed By Non GMO Corn Farmers Reports Wright & Schulte LLC 3Health News:Mirena Lawsuit Filed By Southern Med Law Seeks Compensation For Purported Wrongful Death Following Premature Birth Of Infant 2Health News:Mirena Lawsuit Filed By Southern Med Law Seeks Compensation For Purported Wrongful Death Following Premature Birth Of Infant 3Health News:Mirena Lawsuit Filed By Southern Med Law Seeks Compensation For Purported Wrongful Death Following Premature Birth Of Infant 4Health News:2015 Endeavor Awards Recipients Announced 2Health News:Innovaacom Expands Services and Medical Education Programs into Asia 2
... of doses, lack of protocols for this screening test , ... coronary calcium scan is worth the risk, a new study ... easy. , A team of researchers from the U.S. National ... of radiation exposure from having such a screening test every ...
... Cindy Schwartz, MD, of Hasbro Children,s Hospital has identified ... patients. The new treatment enhances efficacy through dose-dense drug ... high cumulative dose chemotherapy. Schwartz and the researchers of ... the journal Blood (posted in an online ...
... ... the International Stevie Award for Communications Team of the Year for their work on Hear ... loss. , ... July 13, 2009 -- Leading hearing system manufacturer Phonak has won the International Stevie Award ...
... , , , ... one of the nation,s leading consumer-focused private equity firms, today ... StriVectin brand and related assets from affiliates of Klein-Becker. ... care industry, led by Chief Executive Officer Melisse Shaban and ...
... ... in media relations services, explains how PR professionals can add a vital dimension to their ... of Twitter followers (Tweetups). , ... Livingston, NJ (PRWEB) July 13, 2009 -- A white paper just issued by BurrellesLuce ...
... , NEW YORK, July 13 Next week, the Center ... clinics in six states demonstrating that attacks, harassment, discriminatory legal restrictions and ... women,s reproductive rights. The report will be released at a briefing ... July 22 , at 12:30 p.m. in ...
Cached Medicine News:Health News:Coronary Calcium Scans Can Raise Cancer Risks 2Health News:Coronary Calcium Scans Can Raise Cancer Risks 3Health News:Research identifies successful new treatment for Hodgkin's lymphoma, reduces long-term risks 2Health News:Research identifies successful new treatment for Hodgkin's lymphoma, reduces long-term risks 3Health News:Phonak and Hear the World Wins International Stevie Award in Sixth Annual International Business Awards 2Health News:Phonak and Hear the World Wins International Stevie Award in Sixth Annual International Business Awards 3Health News:Catterton Partners Acquires Leading Cosmeceutical Brand StriVectin 2Health News:Catterton Partners Acquires Leading Cosmeceutical Brand StriVectin 3Health News:BurrellesLuce White Paper Gives Advice on Turning Twitter Connections Into Community Building Blocks 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: